Trial intelligence / Profile preview

Tranexamic acid as a hemostatic adjunct to ornipressin during open myomectomy

PACTR201203000369163Not yet recruiting

Sponsor
Aga Khan University
Start
May 2012
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Open-label trial of tranexamic acid and ornipressin in Fibromyoma (LM), sponsored by Aga Khan University. Primary endpoint: Blood loss in each group. Planned start May 2012; status: not yet recruiting.

02

Drugs

tranexamic acidornipressin
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on PACTR201203000369163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201203000369163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call